
BOSTON, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a biotechnology company advancing ...

Curetis To Attend Key Investor and Scientific Conferences In The Fourth Quarter 2018 Amsterdam, ...
Click to continue to site. Closing